Fibrotic disease and the T(H)1/T(H)2 paradigm.
Wynn
Thomas A
TA
Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 50 South Drive, Room 6154, MSC 8003, Bethesda, Maryland 20892, USA. twynn@niaid.nih.gov
D000818:Animals; D018925:Chemokines / Q000378:metabolism; D005347:Fibroblasts / Q000378:metabolism; D005355:Fibrosis / Q000276:immunology* / Q000378:metabolism / Q000628:therapy; D006801:Humans; D018793:Interleukin-13 / Q000378:metabolism; D008264:Macrophages / Q000378:metabolism; D018417:Th1 Cells / Q000276:immunology* / Q000378:metabolism; D018418:Th2 Cells / Q000276:immunology* / Q000378:metabolism; D016212:Transforming Growth Factor beta / Q000378:metabolism
D018925:Chemokines; D018793:Interleukin-13; D016212:Transforming Growth Factor beta